Contributors

Keith Aaronson, MD, Professor of Medicine, University of Michigan, USA

Philip B. Adamson, MD, MSc, Divisional Vice President, Medical Director, Global Clinical Research and Development, Abbott Vascular, California, USA

Felipe Aguel, Circulatory Support Devices Branch, U.S. Food and Drug Administration, Maryland, USA

Sarah Ahlberg, Senior Research Manager, Medtronic, Minnesota, USA

Jeroen Bax, MD, PhD, Professor of Cardiology and Director of Noninvasive Imaging, Leiden University Medical Center, Leiden, Netherlands

Ori Ben-Yehuda, MD, Executive Director, Clinical Trials Center, Cardiovascular Research Foundation, New York, USA

Robert O. Bonow, MD, Max and Lilly Goldberg Distinguished Professor of Cardiology, Feinberg School of Medicine, Northwestern University, Illinois, USA

Robin Bostic, Divisional Vice President, Global Health Economics & Reimbursement, Abbott Vascular, California, USA

Kevin Bourque, Divisional Vice President, Research & Development, Mechanical Circulatory Support, Abbott, California, USA

Todd J. Brinton, MD, Clinical Professor, Medicine – Cardiovascular Medicine, Stanford University, California, USA

Marco Cannella, PhD, Senior Lead Reviewer Cardiac Electrophysiology Devices Branch, U.S. Food and Drug Administration, Maryland, USA

Blasé Carabello, MD, Chief of Cardiology, Brody School of Medicine at East Carolina University and Vidant Medical Center, South Carolina, USA

Deborah G. Castillo, PhD, Former Acting Chief, Cardiac Diagnostics Devices Branch, U.S. Food and Drug Administration, Maryland, USA

Joseph Chin, MD, Deputy Director of the Evidence Development Division, U.S. Centers for Medicare & Medicaid Services, Maryland, USA

Seth Clancy, Senior Director, Global Health Economics & Reimbursement, Edwards Lifesciences, California, USA

Alain Cribier, MD, Professor Emeritus, Rouen University, Mont-Saint-Aignan, France

Donald E. Cutlip, MD, Section Chief of Interventional Cardiology, Beth Israel Deaconess Medical Center, Massachusetts, USA

Anthony DeMaria, MD, Judith and Jack White Chair in Cardiology and Founding Director, Sulpizio Cardiovascular Center at University of California San Diego, USA

Nabil Dib, MD, MSc, Professor of Medicine and Director of Cardiovascular Translational Research, Dignity Health, Arizona, USA

Tonya Dowd, MPH, Global Director, Health Economics and Market Access, Cardiovascular and Specialty Solutions, Johnson & Johnson Medical Devices Companies, California, USA

Carol E. Eberhardt, Distinguished Scientist, Medtronic, Minnesota, USA

Stephen Ellis, MD, Director of the Sones Cardiac Catheterization Laboratory and Co-Director of the Cardiac Genebank, Cleveland Clinic, Ohio, USA

Andrew Farb, MD, Medical Officer and Senior Reviewer, U.S. Food and Drug Administration, Maryland, USA

David J. Farrar, PhD, Director, Research and Scientific Affairs, Abbott, California, USA

Gregory K. Feld, MD, Professor of Medicine and Director, Clinical Cardiac Electrophysiology Program, University of California San Diego Health System, California, USA

Mark Fellman, MS, Acting Deputy Director, Division of Cardiovascular Devices, U.S. Food and Drug Administration, Maryland, USA

Alan G. Fraser, MD, Professor of Cardiology, School of Medicine, Cardiff University, Cardiff, United Kingdom

Brett Gidney, MD, Director, Heart Rhythm Center, California, USA

Paul Grayburn, MD, Director, Cardiology Research, Baylor Scott and White Heart and Vascular Hospital, Texas, USA

Russell Hodge, Vice President of Product Development for Heart Valve Therapy Business, Medtronic, Minnesota, USA

David R. Holmes, MD, Professor of Medicine, Mayo Clinic College of Medicine and Science, Minnesota, USA

Nicole Ibrahim, PhD, Structural Heart Devices Branch Chief, Cardiovascular Devices Division, U.S. Food and Drug Administration, Maryland, USA

Alice Jacobs, MD, Professor of Medicine, Boston University School of Medicine, Massachusetts, USA

Priya Jagasia, MD, Divisional Vice President, Regulatory Affairs, Abbott Vascular, California, USA

Timothy Kelley, Distinguished Engineer, Medtronic, Minnesota, USA

Jeffrey Kepner, Senior Product Development Manager, Medtronic, Minnesota, USA

Morton J. Kern, MD, Chief of Cardiology, Veterans Administration Long Beach Health Care System, California, USA

Spencer King III, MD, Professor of Medicine Emeritus, Emory University School of Medicine, Georgia, USA

Mitchell W. Krucoff, MD, Professor of Medicine/Cardiology, Duke University Medical Center, and Director, Cardiovascular Devices Unit, Duke Clinical Research Institute, North Carolina, USA

Uday N. Kumar, MD, Founder, President, and Chief Executive Officer at Element Science, Inc., and Fellowship Director, Global Biodesign Programs, Stanford University, California, USA

John Laschinger, MD, Chief Medical Officer, Center for Devices and Radiological Health, Office of Clinical Evaluation and Analysis, U.S. Food and Drug Administration, Maryland, USA

Tim Laske, PhD, Vice President of Research and Business Development, Medtronic, Minnesota, USA

Martin B. Leon, MD, Mallah Family Professor of Cardiology, Columbia University Medical Center, and Founder and Chairman Emeritus Cardiovascular Research Foundation, New York, USA

Niall MacAleenan, MD, Deputy Director, Medical Devices, Health Products Regulatory Authority, Dublin, Ireland

Michael Mack, MD, Medical Director, Cardiovascular Surgery, Baylor Health Care System, Texas, USA

Simran Madhani, Senior Associate, MCRA, LLC, Washington, DC, USA

Tom Melvin, MD, Clinical Manager, Medical Devices, Health Products Regulatory Authority, Dublin, Ireland

Chris Mullin, Director of Product Development Strategy, NAMSA, Ohio, USA

Neil K. Nydegger, Esq, Nydegger & Associates, California, USA

Jose Osorio, MD, Medical Director, The Arrhythmia Institute at Grandview, Grandview Medical Center, Alabama, USA

Douglas Packer, MD, Director of Electrophysiology, Mayo Clinic, Minnesota, USA

Francis D. Pagani, MD, Surgical Director of the Adult Heart Transplant Program and Program Director for the Center for Circulatory Support Michigan Medicine Cardiac Surgery Clinic/Cardiovascular Center, University of Michigan, USA

Christopher J. Panarites, PhD, Senior Director, Health Economics & Reimbursement, Abbott, California, USA

Laura E. Leigh Perkins, DVM, PhD, DACVP, Abbott Vascular, California, USA

Ileana L. Piña, MD, MPH, Professor of Medicine, Wayne State University, Michigan, USA

Paul Piscoi, MD, Scientific Policy Officer, European Commission, Brussels, Belgium

David G. Reuter, MD, PhD, Director, Cardiac Innovations, Seattle Children’s Hospital, Washington, USA

Stanton Rowe, Chief Executive Officer, NXT Biomedical, California, USA

Jonathan G. Schwartz, MD, Sanger Heart & Vascular Institute-Charlotte, North Carolina, USA

Chuck Simonton, MD, Chief Medical Officer and Divisional Vice President of Global Medical Affairs, Abbott Vascular, California, USA

Gregg W. Stone, MD, Director of Academic Affairs Mount Sinai Heart Health System, Co-director of Medical Research and Education, The Cardiovascular Research Foundation, New York, USA

Hatem Tadros, Senior Product Development Manager, Medtronic, Minnesota, USA

Elizabeth Thoma, MBA, Senior Manager, Global Health Economics & Reimbursement, Abbott Structural Heart, California, USA

Olga Tkachenko, PhD, Scientific Policy Officer, European Commission, Brussels, Belgium

Patrick Verta, MS, DVM, MD, Vice President, Medical Affairs, Edward Lifesciences, California, USA

Renu Virmani, MD, President, CVPath Institute, Maryland, USA

Roseann White, Former Director of Pragmatic Clinical Trials, Duke Clinical Research Institute, North Carolina, USA

Changfu Wu, PhD, Division of Cardiovascular Devices, Office of Device Evaluation, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Maryland, USA

Uri Yaron, PhD, Worldwide President, Biosense Webster at Johnson & Johnson, California, USA

Magdi Yacoub, MD, Professor of Cardiothoracic Surgery, Imperial College London, United Kingdom

Paul G. Yock, MD, Founder & Director, Stanford Biodesign, and Martha Meier Weiland Professor of Medicine, Stanford University, California, USA

Bram D. Zuckerman, MD, Director, Division of Cardiovascular Devices, U.S. Food and Drug Administration, Maryland, USA